JP2022036990A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022036990A5 JP2022036990A5 JP2021189726A JP2021189726A JP2022036990A5 JP 2022036990 A5 JP2022036990 A5 JP 2022036990A5 JP 2021189726 A JP2021189726 A JP 2021189726A JP 2021189726 A JP2021189726 A JP 2021189726A JP 2022036990 A5 JP2022036990 A5 JP 2022036990A5
- Authority
- JP
- Japan
- Prior art keywords
- epithelial cells
- maximizing
- tight junction
- junction integrity
- integrity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000000968 intestinal effect Effects 0.000 claims description 5
- 210000002919 epithelial cell Anatomy 0.000 claims 18
- 210000001578 tight junction Anatomy 0.000 claims 15
- 102000000591 Tight Junction Proteins Human genes 0.000 claims 13
- 108010002321 Tight Junction Proteins Proteins 0.000 claims 13
- 206010061218 Inflammation Diseases 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 3
- 230000002526 effect on cardiovascular system Effects 0.000 claims 3
- 230000004054 inflammatory process Effects 0.000 claims 3
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 3
- 206010020751 Hypersensitivity Diseases 0.000 claims 2
- 208000008589 Obesity Diseases 0.000 claims 2
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 claims 2
- VEVZSMAEJFVWIL-UHFFFAOYSA-O cyanidin cation Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC=C(O)C(O)=C1 VEVZSMAEJFVWIL-UHFFFAOYSA-O 0.000 claims 2
- 235000020824 obesity Nutrition 0.000 claims 2
- 208000015943 Coeliac disease Diseases 0.000 claims 1
- 208000011231 Crohn disease Diseases 0.000 claims 1
- GCPYCNBGGPHOBD-UHFFFAOYSA-N Delphinidin Natural products OC1=Cc2c(O)cc(O)cc2OC1=C3C=C(O)C(=O)C(=C3)O GCPYCNBGGPHOBD-UHFFFAOYSA-N 0.000 claims 1
- 229920002307 Dextran Polymers 0.000 claims 1
- 208000027244 Dysbiosis Diseases 0.000 claims 1
- 206010061958 Food Intolerance Diseases 0.000 claims 1
- 206010017964 Gastrointestinal infection Diseases 0.000 claims 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 claims 1
- 102100025255 Haptoglobin Human genes 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 206010022489 Insulin Resistance Diseases 0.000 claims 1
- 102000001109 Leukocyte L1 Antigen Complex Human genes 0.000 claims 1
- 108010069316 Leukocyte L1 Antigen Complex Proteins 0.000 claims 1
- 102000019149 MAP kinase activity proteins Human genes 0.000 claims 1
- 108040008097 MAP kinase activity proteins Proteins 0.000 claims 1
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 1
- 102000003945 NF-kappa B Human genes 0.000 claims 1
- 108010057466 NF-kappa B Proteins 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000001280 Prediabetic State Diseases 0.000 claims 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 1
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 1
- 208000025865 Ulcer Diseases 0.000 claims 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 1
- 230000007815 allergy Effects 0.000 claims 1
- 208000006673 asthma Diseases 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 239000013553 cell monolayer Substances 0.000 claims 1
- 230000001684 chronic effect Effects 0.000 claims 1
- 208000021735 chronic enteritis Diseases 0.000 claims 1
- 210000001072 colon Anatomy 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 235000007336 cyanidin Nutrition 0.000 claims 1
- 235000007242 delphinidin Nutrition 0.000 claims 1
- JKHRCGUTYDNCLE-UHFFFAOYSA-O delphinidin Chemical compound [O+]=1C2=CC(O)=CC(O)=C2C=C(O)C=1C1=CC(O)=C(O)C(O)=C1 JKHRCGUTYDNCLE-UHFFFAOYSA-O 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 230000007140 dysbiosis Effects 0.000 claims 1
- 201000006549 dyspepsia Diseases 0.000 claims 1
- MHMNJMPURVTYEJ-UHFFFAOYSA-N fluorescein-5-isothiocyanate Chemical compound O1C(=O)C2=CC(N=C=S)=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 MHMNJMPURVTYEJ-UHFFFAOYSA-N 0.000 claims 1
- 230000002496 gastric effect Effects 0.000 claims 1
- 210000001035 gastrointestinal tract Anatomy 0.000 claims 1
- 230000035987 intoxication Effects 0.000 claims 1
- 231100000566 intoxication Toxicity 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 235000015097 nutrients Nutrition 0.000 claims 1
- 201000009104 prediabetes syndrome Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 150000004666 short chain fatty acids Chemical class 0.000 claims 1
- 230000019491 signal transduction Effects 0.000 claims 1
- 239000002356 single layer Substances 0.000 claims 1
- 208000024891 symptom Diseases 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 108010027843 zonulin Proteins 0.000 claims 1
- 230000035699 permeability Effects 0.000 description 3
- 210000005095 gastrointestinal system Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2021189726A JP7473516B2 (ja) | 2016-10-27 | 2021-11-22 | 腸の健康を促す組成物 |
| JP2024063716A JP2024099590A (ja) | 2016-10-27 | 2024-04-11 | 腸の健康を促す組成物 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2016/059226 WO2018080510A1 (en) | 2016-10-27 | 2016-10-27 | Intestinal health promoting compositions |
| JP2019545873A JP7011885B2 (ja) | 2016-10-27 | 2016-10-27 | 腸の健康を促す組成物 |
| JP2021189726A JP7473516B2 (ja) | 2016-10-27 | 2021-11-22 | 腸の健康を促す組成物 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545873A Division JP7011885B2 (ja) | 2016-10-27 | 2016-10-27 | 腸の健康を促す組成物 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024063716A Division JP2024099590A (ja) | 2016-10-27 | 2024-04-11 | 腸の健康を促す組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022036990A JP2022036990A (ja) | 2022-03-08 |
| JP2022036990A5 true JP2022036990A5 (https=) | 2022-05-10 |
| JP7473516B2 JP7473516B2 (ja) | 2024-04-23 |
Family
ID=62023893
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545873A Active JP7011885B2 (ja) | 2016-10-27 | 2016-10-27 | 腸の健康を促す組成物 |
| JP2021189726A Active JP7473516B2 (ja) | 2016-10-27 | 2021-11-22 | 腸の健康を促す組成物 |
| JP2024063716A Pending JP2024099590A (ja) | 2016-10-27 | 2024-04-11 | 腸の健康を促す組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019545873A Active JP7011885B2 (ja) | 2016-10-27 | 2016-10-27 | 腸の健康を促す組成物 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024063716A Pending JP2024099590A (ja) | 2016-10-27 | 2024-04-11 | 腸の健康を促す組成物 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20190255134A1 (https=) |
| JP (3) | JP7011885B2 (https=) |
| KR (1) | KR20190079641A (https=) |
| CN (1) | CN110636760B (https=) |
| WO (1) | WO2018080510A1 (https=) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190255134A1 (en) * | 2016-10-27 | 2019-08-22 | Nse Products, Inc. | Intestinal health promoting compositions |
| KR102178556B1 (ko) * | 2019-03-21 | 2020-11-13 | 강원대학교산학협력단 | 마늘껍질 추출물을 포함하는 장내균총 개선용 프리바이오틱스 조성물 및 이를 포함하는 기능성 식품 |
| FR3097122B1 (fr) * | 2019-06-11 | 2021-06-18 | Valbiotis | Melange d’extraits de plantes pour son utilisation dans la prevention et/ou le traitement des maladies chroniques inflammatoires de l’intestin |
| CN110283754B (zh) * | 2019-07-11 | 2021-02-02 | 中国科学院北京基因组研究所 | 用于类风湿关节炎炎症状态评估及预后评价的肠道微生物菌群 |
| IT201900019325A1 (it) * | 2019-10-18 | 2021-04-18 | Ghs Gemelli Health System S R L | Miscela comprendente estratti di frutti, e polifenoli estratti da foglie o frutti di Olea Europaea L. e inulina e uso di tale composizione nel trattamento di malattie infiammatorie acute e croniche, localizzate o sistemiche, o conseguenti ad un’ischemia o a un’alterazione della funzionalità dell’endotelio vasale |
| WO2021193703A1 (ja) * | 2020-03-24 | 2021-09-30 | 学校法人 芝浦工業大学 | 中枢神経賦活組成物 |
| KR20210156445A (ko) | 2020-06-18 | 2021-12-27 | 종근당건강 주식회사 | 들쭉나무 열매 분말 또는 추출물을 함유하는 장내 환경 개선용 조성물 |
| CN115988969A (zh) * | 2020-08-25 | 2023-04-18 | 国立大学法人熊本大学 | 用于改善伴随月经产生的不适状态的组合物 |
| JP2023124967A (ja) * | 2022-02-28 | 2023-09-07 | アスパック企業株式会社 | 腸内環境改善剤 |
| CN115645429B (zh) * | 2022-12-12 | 2023-05-16 | 汤臣倍健股份有限公司 | 一种花色苷组合物及其应用 |
| JP2026503891A (ja) * | 2023-01-04 | 2026-02-02 | エヌエスイー プロダクツ、インク． | 代謝健康促進組成物 |
| CN116790402B (zh) * | 2023-01-14 | 2024-05-14 | 西北农林科技大学 | 一株具有抗炎特性的单形拟杆菌菌株、培养方法及应用 |
| CN117085117B (zh) * | 2023-09-14 | 2024-03-12 | 浙江花开星辰生物科技有限公司 | 一种洋甘菊提取物的抗幽门螺旋杆菌组合物及其制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU6801200A (en) * | 1999-08-27 | 2001-03-26 | Amway Corporation | Dietary food supplement containing natural cyclooxygenase inhibitors |
| US8337914B2 (en) * | 2002-02-27 | 2012-12-25 | Access Business Group International Llc | Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation |
| JP2004099578A (ja) | 2002-09-04 | 2004-04-02 | Oriza Yuka Kk | 美肌用組成物 |
| US20070243268A1 (en) * | 2005-11-07 | 2007-10-18 | Jaffe Russell M | Compositions for regulating intestinal disorders and methods of use thereof |
| EP1882473A1 (en) * | 2006-07-28 | 2008-01-30 | Indena S.P.A. | Use of anthocyanosides to prepare formulations for the treatment of mucositis induced by antitumoral drugs |
| JP2008271878A (ja) * | 2007-04-27 | 2008-11-13 | Wakasa Seikatsu:Kk | 新規飲食品 |
| JP5877902B2 (ja) | 2011-08-17 | 2016-03-08 | マイクロバイオーム セラピューティクス，エルエルシー | バクテロイデス門の胃腸管微生物相対フィルミクテス門の微生物相の比を上昇させるための組成物および製剤の使用 |
| EP2682005A1 (en) * | 2012-07-05 | 2014-01-08 | Symrise AG | A dietary supplement composition |
| EP2710901A1 (en) * | 2012-09-20 | 2014-03-26 | Symrise AG | Dietary supplement compositions |
| US20140128333A1 (en) * | 2012-11-02 | 2014-05-08 | Maqui New Life S.A. | Compounds, Compositions, and Methods for Decreasing Intestinal Glucose Uptake and Inducing Incretin Release |
| AU2014236655B2 (en) * | 2013-03-15 | 2017-06-29 | Mars, Incorporated | Edible pet chew and method of making the same |
| US20190255134A1 (en) * | 2016-10-27 | 2019-08-22 | Nse Products, Inc. | Intestinal health promoting compositions |
-
2016
- 2016-10-27 US US16/346,100 patent/US20190255134A1/en not_active Abandoned
- 2016-10-27 WO PCT/US2016/059226 patent/WO2018080510A1/en not_active Ceased
- 2016-10-27 CN CN201680091887.7A patent/CN110636760B/zh active Active
- 2016-10-27 JP JP2019545873A patent/JP7011885B2/ja active Active
- 2016-10-27 KR KR1020197015224A patent/KR20190079641A/ko active Pending
-
2021
- 2021-11-22 JP JP2021189726A patent/JP7473516B2/ja active Active
-
2024
- 2024-04-11 JP JP2024063716A patent/JP2024099590A/ja active Pending
- 2024-08-12 US US18/801,755 patent/US20250114419A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2022036990A5 (https=) | ||
| Sheng et al. | Immunomodulatory effects of inulin and its intestinal metabolites | |
| Hamer et al. | The role of butyrate on colonic function | |
| Tayebi Khosroshahi et al. | Effect of high amylose resistant starch (HAM‐RS2) supplementation on biomarkers of inflammation and oxidative stress in hemodialysis patients: a randomized clinical trial | |
| Zheng et al. | Prebiotic mannan-oligosaccharides augment the hypoglycemic effects of metformin in correlation with modulating gut microbiota | |
| JP2024099590A5 (https=) | ||
| Patel et al. | Clinical science workshop: targeting the gut-liver-brain axis | |
| JP6905140B2 (ja) | 炎症性腸疾患の治療におけるアルテミシニン誘導体の医学的使用 | |
| Xia et al. | Konjac oligosaccharides attenuate DSS-induced ulcerative colitis in mice: mechanistic insights | |
| JP2020513014A5 (https=) | ||
| US20250025436A1 (en) | Human dietary supplement and method for treating digestive system and immune-related disorders | |
| Qin et al. | Porcine-derived antimicrobial peptide PR39 alleviates DSS-induced colitis via the NF-κB/MAPK pathway | |
| Chen et al. | Orally administered Chrysophyta polysaccharide ameliorates DSS-induced colitis via intestinal barrier improvement, oxidative stress regulation, NF-κB pathway inhibition, and gut microbiota modulation | |
| Song et al. | Probiotic spore-derived multifunctional nanoparticles for enhanced ulcerative colitis treatment by activating metabolic pathways and repairing epithelial barrier | |
| CN114259507B (zh) | 一种小克里斯滕森氏菌在制备治疗和/或预防高尿酸相关疾病的药物中的应用 | |
| CN115606802A (zh) | 番茄红素在制备修复肠屏障损伤的产品中的应用 | |
| Amiot | Gastro-entéropathies exsudatives | |
| Ying et al. | The relationship between intestinal flora and chronic diseases: research progress | |
| Fu et al. | Research progress on Prunella vulgaris and its monomers in protecting against ulcerative colitis | |
| Silveira et al. | High-fiber diets in gastrointestinal tract diseases | |
| Hunter et al. | 23 Diseases of the gastrointestinal tract | |
| Lee et al. | Lycium barbarum polysaccharides and/or Bifidobacterium longum exert anti-inflammation and modulate gut microbiota in rats with dextran sulfate sodium-induced ulcerative colitis | |
| CN117224554A (zh) | Capilliposide A在制备治疗溃疡性结肠炎药物中的应用 | |
| Cui et al. | Complex interactions of gut-derived short-chain fatty acids in hyperuricemia and gout pathophysiology | |
| CN116570596A (zh) | 维立西呱在治疗急性溃疡性结肠炎中的应用 |